December 1, 2016 / 4:15 PM / a year ago

BRIEF-UnitedHealth: Sarepta's drug Exondys 51 to be covered for DMD patients

Dec 1 (Reuters) - UnitedHealth Group Inc

* UnitedHealth: Sarepta’s drug Exondys 51 to be covered for Duchenne muscular dytrophy patients after confirmed diagnosis, submission of medical records

* UnitedHealth: Initial authorization for Exondys 51 for no more than 4 weeks; reauthorization for no more than 6 months Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below